Duchenne muscular dystrophy (DMD) is a genetic disorder characterized by progressive muscle degeneration due to a mutation in the dystrophin gene, leading to muscle weakness and functional decline. Symptoms typically appear in early childhood, including frequent falls and difficulty with movement, and progression occurs through five stages from diagnosis to late non-ambulatory. Treatments such as physical therapy and corticosteroids like deflazacort are recommended to manage the condition and improve quality of life.